Precautions for taking levodopa: rhabdomyolysis and medication safety
Livazeb medication should be cautious of the risk of rhabdomyolysis, a serious adverse reaction that can lead to renal failure or even death. The following provides a detailed explanation of precautions in terms of monitoring indicators, risk populations, symptom identification, and treatment measures.
1. High risk population screening
(1) Elderly patients (≥ 65 years old) have a 2.4-fold increased risk of myopathy.
(2) Patients with renal insufficiency (eGFR<60ml/min) have a reduced drug clearance rate.
(3) Combination use of statin/beta lipid-lowering drugs in patients.
(4) Uncontrolled hypothyroidism.
2. Baseline assessment before medication
(1) Must check creatine kinase (CK): If the baseline value is>5 times ULN, medication should be temporarily suspended.
(2) Liver and kidney function: ALT/AST ≤ 3 times ULN, Scr ≤ 1.5 times UL.
(3) Electrolytes: correct hypokalemia/hypomagnesemia.
(4) Combination medication review: Avoid using strong CYP3A4 inhibitors in combination.
3. Monitoring during treatment
(1) CK monitoring: once a week in the first month and once a month thereafter.
(2) Creatinine monitoring: Test immediately when muscle pain occurs.
(3) Urine volume observation: maintain>1500ml/day.
(4) Symptom inquiry: Focus on skeletal muscle pain/weakness.
4. Identification of rhabdomyolysis
(1) Typical symptoms: muscle pain/tenderness, brownish urine, and general fatigue.
(2) Laboratory standard: CK>1000U/L with elevated creatinine.
(3) Critical value: CK>5000U/L or blood potassium>6mmol/L.
5. Emergency response process
(1) Immediately discontinue medication and seek hospitalization for treatment.
(2) Intravenous hydration: physiological saline 200-300ml/h.
(3) Alkalinization of urine: Sodium bicarbonate maintains urine pH>7.0.
(4) Blood purification: Consider continuous CK>10000U/L.
6. Principle of Restarting Medication
(1) CK restored to<2 times ULN.
(2) Stable renal function (Scr fluctuation<20%).
(3) Reduce usage by 50%.
(4) Strengthen monitoring to CK twice a week.
Disclaimer：《Precautions for taking levodopa: rhabdomyolysis and medication safety》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！